Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Here’s Why Acceleron Pharma Stock Fell 12% in September [The Motley Fool]

Acceleron Pharma Inc. (XLRN) 
Last acceleron pharma inc. earnings: 2/27 04:05 pm Check Earnings Report
Company Research Source: The Motley Fool
Here’s Why Acceleron Pharma Stock Fell 12% in September What happened Shares of Acceleron Pharma Global Market Intelligence biotech So what Interestingly, the drug increased FSHD is characterized by muscle weakness, so gaining strength, rather than just muscle, is obviously important. Given the disappointing phase data, Acceleron doesn't plan to continue development of ACE-08 in patients with FSHD. Image source: Getty Images. Now what Acceleron Pharma is also testing ACE-08 in Charcot-Marie-Tooth (CMT) disease, a group of disorders that affect nerves, which results in muscle atrophy and weakness. The phase study is expected to read out in the first quarter of next year. Based on the FSHD study, it's possible that the drug might be helping patients grow muscles that aren't functional, although management noted that CMT has a different pathophysiology than FSHD, so perhaps Acceleron will see different results. Fortunately, these are midstage studies that are relatively cheap to run c Show less Read more
Impact Snapshot
Event Time:
XLRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for XLRN alerts
Opt-in for
XLRN alerts

from News Quantified
Opt-in for
XLRN alerts

from News Quantified